扁桃体
阿霉素
肽
化学
药物输送
组合化学
药品
生物物理学
体外
聚乙二醇
自愈水凝胶
控制释放
靶向给药
动力学
纳米技术
共轭体系
癌细胞
细胞毒性
小分子
体内
PEG比率
A549电池
材料科学
基质(水族馆)
生物相容性材料
癌症治疗
细胞培养
纳米颗粒
基质(化学分析)
毒品携带者
HEK 293细胞
前药
作者
Carolyn M. Watkins,Samuel Hallam,Mariah J. Austin,Adrianne M. Rosales
标识
DOI:10.1002/adhm.202504277
摘要
Combination cancer therapies offer to minimize toxicity and alleviate patient burden, but a key challenge is independent control over the release of multiple therapeutics, especially in systems with chemotherapeutic drugs of similar size and structure. Due to MMP upregulation in cancer microenvironments, matrix metalloproteinase (MMP)-degradable linkers are often exploited for targeted release; however, their short substrates exhibit overlap with multiple proteases, which confounds kinetic control. Here, a library of MMP-responsive "peptomer" drug linkers was developed to control release on fast and slow timescales. Peptomers are hybrid molecules of peptides and non-natural peptoids (N-substituted glycines), which hinder proteolytic susceptibility. Systematic variation of peptoid substitutions within a pan-MMP-cleavable peptide sequence yielded distinct degradation kinetics to multiple MMPs. Two chemotherapeutics, doxorubicin and geldanamycin, were conjugated to peptomer linkers and incorporated into polyethylene glycol (PEG)-based hydrogels for sequential delivery. Fluorogenic and mass spectrometry-based assays demonstrated decoupled release of each drug in response to MMP-2 and MMP-9. In vitro studies using MDA-MB-231 and A549 cells showed that cell death rates correlated with the order of drug release. These findings highlight peptomers as modular, biocompatible linkers capable of kinetic control over multiple therapeutic agents, providing a versatile platform for improving the precision of combination drug delivery systems.
科研通智能强力驱动
Strongly Powered by AbleSci AI